The risk of ovarian cancer in BRCA1 mutation carriers, which ranges from 39 to 46% by the age of 70, and for BRCA2 mutation carriers, ranging from 10 to 27% by the same age, underscores the impact of these genetic alterations on disease incidence [1]. The gene discussed is BRCA2; the disease is ovarian cancer.